Navigation Links
Singulex Closes $19 Million Financing Round
Date:1/12/2009

ALAMEDA, Calif., Jan. 12 /PRNewswire/ -- Singulex, Inc. today announced that it has closed a $19 million financing round, led by JAFCO Co., Ltd. and supported by existing investors including OrbiMed Advisors and Fisk Ventures. The financing round will support the commercialization of Singulex technologies in the diagnostics market. As part of the financing, Hironori Hozoji, investment officer for JAFCO Life Science Investment, will join the company's Board of Directors.

"With these funds, we are confident we have the resources to develop our immunoassay technology for use in the diagnostics field," said Philippe Goix, PhD, CEO of Singulex. "Already, the assays we have developed and optimized for our pharmaceutical partners have enabled them to see biomarker level differences in blood samples with and without drugs that they had not been able to see before, thus offering new insights for their clinical trials."

Singulex has closed partnerships with multiple large pharmaceutical companies to use Erenna technology and immunoassays to help them better understand the effects of their compounds early in preclinical studies and clinical trials. With its ability to detect and measure minute protein biomarker changes at very low levels, Singulex's technology also has significant potential for clinical applications in personalized medicine across multiple diseases.

Singulex will use the funds from this financing to deploy its product and services in the emerging molecular clinical diagnostic market. Initially, the company will focus on cardiovascular disease risk diagnostics using its assay platform for the biomarker c Troponin I (cTnI), a well-validated marker for cardiac necrosis.

"Singulex's steady progress in publishing strong data from premier medical schools in the country indicated that the Erenna technology can make significant contributions to the diagnostics field, specifically in the cardiov
'/>"/>

SOURCE Singulex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program
2. Karolinska Development Closes Fully Subscribed New Share Issue
3. Concentric Medical Closes on $15 Million Financing
4. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
5. Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
6. AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
7. MicroPhage Closes Latest Financing
8. Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
9. CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
10. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
11. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... (the "Company") (Nasdaq: CMED ), a leading China -based advanced in-vitro,diagnostic ("IVD") company, today ... Investor Conference Date ... Rodman & Renshaw Annual March 7-9, 2010 ... ... Conference, Credit Suisse Asian ...
(Date:2/8/2010)... to present the critical processes that comprise a more accurate ... ... Chicago, IL (PRWEB) February 8, 2010 ... software, today announced that both Kristin Lucas and Kelly Larrabee, ... at the CBI Forecasting & Budgeting conference at the Marriott ...
(Date:2/6/2010)... developing new sensors to detect chemical agents and illegal ... threat of terrorist attacks. , The devices will use ... scene to gather a sample which is then analysed ... of chemicals within seconds. This will allow better, faster ... , The scanning instrument will use Raman Spectroscopy ...
(Date:2/5/2010)... of Valencia (UV) has confirmed that the substance used ... Lixus, in Morocco, was pine resin. The scientists also ... could be fragments of material used for iron-working. , ... discovered a sealed amphora among the remains at Lixus, ... in Morocco. Since then, researchers from the Department of ...
Breaking Biology Technology:China Medical Technologies to Participate Investor Conferences in March 2010 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4New technology detects chemical weapons in seconds 2Chemical analyses uncover secrets of an ancient amphora 2
... Virco Lab, Inc. a leader in HIV resistance testing ... SmartGene, Inc., a provider of novel services for the ... and physicians with greater insight into HIV drug resistance ... HIV resistance reports to an innovative secure Web-based system. ...
... SHP,NASDAQ: SHPGY ), the global specialty biopharmaceutical company, will announce,first quarter ... press release will be issued at: ... ... Live conference call for investors: , Angus Russell, Chief ...
... Evaluate Safety, Proof of Mechanism of a Potential Oral ... April 20 Amira Pharmaceuticals, Inc., announced today the ... its internally discovered oral drug candidate for the treatment ... the arachidonic acid pathway.AM211 is an oral, selective antagonist ...
Other Biology Technology:Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians 2Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians 3Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians 4Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009 2Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist 2
(Date:2/8/2010)... the California Institute of Technology (Caltech) and their ... money to a specific structure in the brainthe ... online issue of the journal Proceedings of ... insight into economic behavior, and also into the ... of tissue located in the medial temporal lobes. ...
(Date:2/8/2010)... , Feb. 8 With the ... Massachusetts resulting in the loss of the ... with the promise of universal coverage for the majority ... & Poor,s Equity Research.  President Obama recently noted the ... passing what has been for many a long sought ...
(Date:2/8/2010)... common disorder of the senses. Tragically, it commonly strikes ... to learn speech and language. In many cases, ... over a long period of months to years, but ... happens, making prospects for prevention and cure very slim. ... to be due to defects in just one gene ...
Breaking Biology News(10 mins):Caltech neuroscientists discover brain area responsible for fear of losing money 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9Mice shed new light on causes of childhood deafness 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3Delcath Systems Announces Completion of Public Offering 6385 1Delcath Systems Announces Completion of Public Offering 6385 2Common pain relief medication may encourage cancer growth 61644 1Common pain relief medication may encourage cancer growth 61644 2Common pain relief medication may encourage cancer growth 61644 3
... have support from family while they,re breast-feeding may be ... rapidly than other primates, new research suggests. , Social ... allows their bodies to prepare for their next pregnancy. ... to what degree this is related to our cultural ...
... conservation biologist at the University of Leicester, Dr David Harper, ... Naivasha in Kenya, today warned that cut-price Valentine roses exported ... , Dr Harper, of the University,s Department of Biology where ... by companies that had no concern for the environment were ...
... acute and chronic symptoms in joints, muscles and the ... which 80,000 people in Germany contract every year. Heidelberg ... accurately. Using a cryo-tomography microscope, the previously unknown detailed ... three dimensions. One finding that borrelia types in ...
Other Biology News:Social support during breast-feeding helps humans have more children 2Social support during breast-feeding helps humans have more children 3Cheap love costs the Earth 2Tiny details in three dimensions 2
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... 3000 drug discovery system miniaturizes, integrates ... Using LabChip technology, the LabChip ... serial, continuous flow fashion. LabChip assays ... results exceeds what is achievable in ...
... range are part of your production or ... particle size is important to you. You ... the component populations in your sample every ... uses Photon Correlation Spectroscopy (PCS) , which ...
... Fermentation System to achieve high experimental ... maximum information output 4 up ... with small-scale requirements provides users with ... E.coli, Pichia pastoris, yeast, fungi or ...
Biology Products: